¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"contact activation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact cheilitis
    Á¢ÃËÀÔ¼ú¿°
  • contact comfort
    Á¢ÃËÀ§¾È
  • contact compound scan
    Á¢Ã˺¹ÇÕ½ºÄµ
  • contact dermatitis
    Á¢ÃËÇǺο°
  • contact gunshot wound
    Á¢»çÃÑ»ó
  • contact hypersensitivity
    Á¢Ã˰ú¹Î(Áõ)
  • contact immunotherapy
    Á¢Ã˸鿪¿ä¹ý
  • contact infection
    Á¢Ã˰¨¿°
  • contact inhibition
    Á¢Ã˾ïÁ¦
  • contact irradiation
    Á¢ÃËÁ¶»ç¹ý
  • contact lens
    ÄÜÅÃÆ®·»Áî, Á¢ÃË·»Áî
  • contact media
    Á¢Ã˸Ű³¹°
  • contact radiography
    ±ÙÁ¢¹æ»ç¼±ÃÔ¿µ(¼ú)
  • contact scan
    Á¢Ã˽ºÄµ
  • contact scanner
    Á¢Ã˽ºÄ³³Ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact cheilitis
    Á¢ÃËÀÔ¼ú¿°
  • contact comfort
    Á¢ÃËÀ§¾È
  • contact dermatitis
    Á¢ÃËÇǺο°
  • contact hypersensitivity
    Á¢Ã˰ú¹Î
  • contact immunotherapy
    Á¢Ã˸鿪¿ä¹ý
  • contact infection
    Á¢Ã˰¨¿°
  • contact inhibition
    Á¢Ã˾ïÁ¦
  • contact irradiation
    Á¢ÃËÁ¶»ç¹ý
  • contact lens
    ÄÜÅÃÆ®·»Áî, Á¢ÃË·»Áî
  • contact media
    Á¢Ã˸Ű³¹°
  • contact radiography
    ±ÙÁ¢ÃÔ¿µ¼ú
  • contact scan
    Á¢Ã˽ºÄµ
  • contact scanner
    Á¢Ã˽ºÄ³³Ê
  • contact scanning
    Á¢Ã˽ºÄ³´×
  • contact stomatitis
    Á¢ÃËÀԾȿ°, Á¢Ã˱¸³»¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • activation
    Ȱ¼ºÈ­
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®(¡­ÝÂà°), ¹æ»çÈ­(Û¯ÞÒûù)ºÐ¼®.
  • activation analysis
    ¹æ»çÈ­ºÐ¼®, Ȱ¼ºÈ­ºÐ¼®
  • activation detector
    Ȱ¼ºÈ­ ŽÁö±â
  • activation energy
    Ȱ¼ºÈ­¿¡³ÊÁö
  • activation gate
    °³¹æ °ü¹®(ËÒÛÁμڦ)
  • activation process
    Ȱ¼ºÈ­°úÁ¤.
  • activation, polyclonal
    ´Ù¼¼Æ÷±ºÈ°¼º, ¿©·¯¹«¸®È°¼º
  • activation, polyclonal B cell
    ´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
  • heat of activation
    Ȱ¼ºÈ­¿­(üÀàõûýæð)
  • photochemical activation
    ±¤È°¼ºÈ­(Ë´Ì· ËÛÌ´).
  • plasmin activation inhibitor
    Çö󽺹ÎȰ¼ºÈ­¾ïÁ¦Á¦(¡­üÀàõûùåäð¤ð¥)
  • polyclonal B cell activation
    B¼¼Æ÷ ´Ù(¼ö)Ŭ·ÐȰ¼º, B¼¼Æ÷ ¿©·¯¹«¸®È°¼º
  • polyclonal activation
    ´Ù(¼ö)Ŭ·ÐȰ¼º, ¿©·¯¹«¸®È°¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • islet-activation factor
    ¶û°Ô¸£Çѽº»ù Ȱ¼ºÀÎÀÚ, ¹éÀÏÇØ±Õµ¶¼Ò
  • macrophage,activation of
    Ȱ¼ºÈ­(üÀàõûù)
  • neutron activation analysis
    Áß¼ºÀÚ¹æ»çÈ­ºÐ¼®(~Û¯ÞÒûùÝÂà°).
  • photochemical activation
    ±¤È°¼ºÈ­(Ë´Ì· ËÛÌ´).
  • plasmin activation inhibitor
    Çö󽺹ÎȰ¼ºÈ­¾ïÁ¦Á¦(¡­üÀàõûùåäð¤ð¥)
  • polyclonal B cell activation
    B¼¼Æ÷ ´Ù(¼ö)Ŭ·ÐȰ¼º, B¼¼Æ÷ ¿©·¯¹«¸®È°¼º
  • polyclonal activation
    ´Ù(¼ö)Ŭ·ÐȰ¼º, ¿©·¯¹«¸®È°¼º
  • sleep activation
    ¼ö¸éºÎȰ(¹ý)(¡­Ý¥üÀÛö) ³úÆÄ(Òà÷î)ÀÇ .
  • thermal activation
    ¿­È°¼ºÈ­¹ÝÀÀ(æðüÀàõûù Úãëë).
  • tissue plasminogen activation
    Á¶Á÷ ÇöóÁî¹Ì°Õ Ȱ¼º
  • tissue plasminogen activation inhibitor
    Á¶Á÷ ÇöóÁî¹Ì³ë°Õ Ȱ¼º ¾ïÁ¦ÀÎÀÚ
  • trypsinogen activation peptide(TAP)
  • ventricular activation
    ½É½ÇÈïºÐ(ãýãøýéÝÇ).
  • ventricular activation
    ½É½ÇÈïºÐ(ãýãøýéÝÇ)
  • ventricular activation time
    ½É½ÇÈïºÐ½Ã°£(ãýãøýéÝÇãÁÊà).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • feed-forward activation
    ¾Õ¸ÔÀÓ È°¼ºÈ­ (üÀàõûù)
  • gene activation
    À¯ÀüÀÚ È°¼ºÈ­(ë¶îîí­üÀàõûù)
  • macrophage activation factor
    ´ë½Ä¼¼Æ÷Ȱ¼ºÀÎÀÚ(ÓÞãÝá¬øàüÀàõì×í­)
  • neutron activation alalysis
    Áß¼ºÀÚ ¹æ»çÈ­ºÐ¼®(ñéàõí­Û¯ÞÒûùÝÂà°)
  • reciprocal activation
    »óº¸ Ȱ¼ºÈ­(ßÓÜÍüÀàõûù)
  • upstream activation sites
    À­ÂÊ È°¼ºÈ­(üÀàõûù)ÀÚ¸®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ADR activation, depression, repetition [in bone remodeling]; adrenodoxin reductase; Adriamycin; adverse ...
AE above-elbow [amputation]; acrodermatitis enteropathica; activation energy; adult erythrocyte; advers...
AECD allergic eczematous contact dermatitis
ARAM antigen recognition activation motif
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CS Contact sensitivity
ICD Irritant contact dermatitis
NCT Non Contact Tonometer
SCL Soft contact lens
% C contact
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • contact angle
    Á¢ÃË °¢
    °íü Ç¥¸é»ó¿¡ ¿ë¾×ÀÇ ¹æ¿ïÀ» ¶³¾î¶ß¸± °æ¿ì, °íü ¸é°ú ¾×ÀÚÀ¯Ç¥¸éÀÌ ÀÌ·ç´Â °¢.
  • contact area
    Á¢Ã˺Î
  • contact cheilitis
    Á¢Ã˼º ±¸¼ø¿°
  • contact dermatitis
    Á¢Ã˼º ÇǺο°, Á¢ÃË ÇǺο°
    ¿ÜºÎÀÇ ¹°Áú¿¡ Á¢ÃËÇÔÀ¸·Î½á ÀϾ´Â ÇǺÎÀÇ ¿°ÁõÀÌ´Ù. À̸¥¹Ù ÇǺΰ¡ Çã´Â °ÍÀ¸·Î °¡·Á¿òÀÌ Æ¯Â¡ÀÌ´Ù. ±Þ¼º ½ÀÁø°ú °°Àº Áõ¼¼¸¦ ¶ìÁö¸¸, ¿ÜºÎ¿¡¼­ ÀÛ¿ëÇϴ ƯÁ¤ÀÇ ¹°Áú¿¡ ´ëÇÑ ¹ÝÀÀÀ¸·Î¼­ ÀϾ´Â Á¡ÀÌ ½ÀÁø°ú ´Ù¸£´Ù. ¹ßº´Çϱ⠽¬¿î ¹°Áú·Î´Â ¿Ì³ª¹«, °Ë¾ç ¿Ì³ª¹«, ¹«È­°ú³ª¹«, ÀºÇ೪¹« µîÀ» ºñ·ÔÇÏ¿©, µµ·á, ÇÕ¼º ¼öÁö Á¦Ç°, ÇÇÇõ Á¦Ç°, °í¹« Á¦Ç°, Å©·Ò µµ±Ý, ¾àǰ, È­Àåǰ·ù ¹× ÇÕ¼º ¼¶À¯·Î ¸¸µç ¼Ó¿Ê µîÀ» µé ¼ö ÀÖ´Ù.
  • contact infection
    Á¢ÃË °¨¿°
    º¸±ÕÀÚ, ¶Ç´Â º´¿øÃ¼°¡ ºÎÂøÇÑ ÀǺ¹, ¹°Ç° µî¿¡ Á÷Á¢ ´ê¾Æ ÇǺγª Á¡¸·À¸·Î °¨¿°µÇ´Â Àü¿°º´ÀÇ ÀüÆÄ ¾ç½Ä. ÀÓÁú, ¸Åµ¶, Æ®¶óÄÚ¸¶ µîÀÌ ´ëÇ¥Àû ÁúȯÀÌ´Ù. ȯÀÚ³ª º¸±ÕÀÚÀÇ º´¿øÃ¼°¡ ±âħ, Àçä±â, ´ëÈ­ µîÀ» ÅëÇÏ¿© »ç¶÷ÀÇ ÄÚ³ª ¸ñ±¸¸ÛÀÇ Á¡¸·¿¡ ºñ»ê, ºÎÂøÇÏ¿© °¨¿°À» ÀÏÀ¸Å°´Â ºñ¸» °¨¿°µµ Á¢ÃË °¨¿°¿¡ Æ÷ÇÔ½ÃŲ´Ù. ÀÎÇ÷翣ÀÚ, Æó°áÇÙ µîÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
  • contact irradiation
    ±ÙÁ¢ Á¶»ç, ±ÙÁ¢ Á¶»ç¹ý
  • contact media
    Á¢ÃËÁ¦
  • contact mode
    Á¢ÃËÇü
  • contact potential difference
    Á¢ÃË ÀüÀ§Â÷
  • contact scan
    Á¢ÃË ½ºÄµ
  • contact surface
    Á¢Ã˸é
    °£È¤ »óÇÏ Ä¡¾Æ°£ ±³ÇÕ¸é Á¢ÃËÀ» °¡¸®Å°´Â °æ¿ìµµ ÀÖ´Ù.
  • contact time
    Á¢ÃË ½Ã°£
  • damaging contact
    À§ÇØ Á¢ÃË
  • final centric relation occlusal contact
    ÃÖÁ¾ Áß½ÉÀ§ ±³ÇÕ Á¢ÃË
  • heavy posterior contact
    ±¸Ä¡ºÎ °ú´Ù Á¢ÃË
    ±³ÇÕ ÀÌ»óÀ¸·Î ÀÎÇÑ ±¸Ä¡ºÎ °ú´Ù Á¢ÃËÀº ÅΰüÀý Àå¾Ö, ¶Ç Ä¡¾ÆÀÇ ½ÉÇÑ ¸¶¸ð°¡ ÀϾ ¼ö ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
trans-activation (genetics) Increased rate of gene expression directed by either viral or cellular proteins. These regulatory factors (diffusible gene products) act in trans -- that is, act on homologous or heterologous molecules of DNA. (cis-acting factors act only on homologous molecules.)
(12 Dec 1998)
energy of activation Energy that must be added to that already possessed by a molecule or molecules in order to initiate a reaction; usually expressed in the Arrhenius equation relating a rate constant to absolute temperature.
(05 Mar 2000)
enzyme activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1) activation by ions (activators); 2) activation by cofactors (coenzymes); and 3) conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
(12 Dec 1998)
juxtacrine activation Activation of target cells by membrane anchored growth factors, also used for activation of leucocytes by PAF bound to endothelial cell surface.
(18 Nov 1997)
feedback activation The activation of an enzyme by an end product of a biochemical pathway in which that enzyme plays a part. For example, the activation of factors VIII and V by thrombin during blood clotting.
(05 Mar 2000)
feed-forward activation The activation of an enzyme by a precursor of the substrate of that enzyme.
(05 Mar 2000)
upstream activation site A DNA sequence that regulates transcription like an enhancer but does notwork if its located downstream from a promoter.
(09 Oct 1997)
low-activation materials <radiobiology> In fission reactors, one is forced to deal with the radioactive byproducts of the fission process, but in fusion reactors one generally has a choice of what materials to expose to neutrons produced by the fusion process. A major problem for fusion reactors is developing materials (such as for the reactor vacuum vessel structure) which can be exposed to high levels of neutron bombardment without becoming permanently radioactive. Candidate structural materials which have relatively low induced radiactivation (generally relative to stainless steel) are known as low-activation materials, these include titanium, vanadium, and silicon-carbide.
(09 Oct 1997)
lymphocyte activation <haematology> The change in morphology and behaviour of lymphocytes exposed to a mitogen or to an antigen to which they have been primed. The result is the production of lymphoblasts, cells that are actively engaged in protein synthesis and that divide to form effector populations. Should not be confused with transformation of the type associated with oncogenic viruses and activation is therefore perhaps a better term.
(18 Nov 1997)
allergic contact dermatitis A delayed type IV allergic reaction of the skin with varying degrees of erythema, oedema, and vesiculation resulting from cutaneous contact with a specific allergen.
Synonym: contact allergy.
(05 Mar 2000)
balancing contact The contact's between upper and lower dentures on the balancing or mediotrusive side for the purpose of stabilizing the dentures, the contact's between upper and lower dentures at the opposite side from the working or laterotrusive side (anteroposteriorly or laterally) for the purpose of stabilizing the dentures, the contact's between upper and lower natural or artificial teeth at the opposite side from the working or laterotrusive side.
Synonym: balancing occlusal surface.
(05 Mar 2000)
centric contact The relation of opposing occlusal surfaces which provides the maximum planned contact and/or intercuspation, the occlusion of the teeth when the mandible is in centric relation to the maxillae.
Synonym: centric contact.
(05 Mar 2000)
microradiography, contact <microscopy> A method of making micrographs by means of X-rays. The specimen is placed close to a fine-grained photographic emulsion at some distance from the X-ray source. The X rays pass through the specimen and the differential absorption and the scattering of the radiation is recorded by the emulsion. The resulting negative is examined and photographed through a light microscope.
(05 Aug 1998)
close contact infection <epidemiology> An infection which requires close contact, other than sexual contact, between susceptible and infectious individuals, for transmission.
(05 Dec 1998)
contact A mutual touching of two bodies or persons.
Origin: L. Contactus = a touching together
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact maker
    (Àü·ùÀÇ)Á¢Ã˱â
  • contact man
    (°Å·¡µîÀÇ)Áß°³ÀÚ;Á¤º¸Á¦°øÀÚ;(°ü°ø¼­µî¿¡ ´ëÇÑ)¼·¿ÜÀÚ;(½ºÆÄÀ̵îÀÇ)¿¬¶ô¿ø
  • contact metamorphism
    Á¢Ã˺¯¼ºÀÛ¿ë
  • contact mine
    Ã˹߼ö·Ú(±â·Ú,Áö·Ú)
  • contact paper
    ¹ÐÂø(ÀÎÈ­)Áö
  • contact potential
    Á¢ÃË ÀüÀ§Â÷
  • contact print
    ¹ÐÂø ÀÎÈ­
  • contact process
    (Ȳ»êÁ¦Á¶ÀÇ)Á¢Ã˹ý 0
  • contact visit
    Á¢Ã˹湮(¼ö°¨ÀÚ¿Í ¹æ¹®ÀÚÀÇ ¾Ç¼ö.Æ÷¿ËµîÀÌ Çã¿ëµÊ)
  • eye contact
    ½Ã¼±ÀÌ ¸¶ÁÖħ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á